Cullen/Frost Bankers’s Boston Scientific BSX Stock Holding History

Cullen/Frost Bankers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.3M	Sell	339,661 -13,005	-4%	-$1.04M	0.24%	90
2025 Q4	$33.6M	Sell	352,666 -2,703	-0.8%	-$265K	0.37%	55
2025 Q3	$34.7M	Sell	355,369 -5,633	-2%	-$583K	0.4%	51
2025 Q2	$38.8M	Buy	361,002 +203	+0.1%	+$20.5K	0.49%	50
2025 Q1	$36.4M	Sell	360,799 -3,475	-1%	-$350K	0.51%	46
2024 Q4	$32.5M	Sell	364,274 -5,098	-1%	-$449K	0.44%	51
2024 Q3	$31M	Buy	369,372 +5,924	+2%	+$467K	0.42%	57
2024 Q2	$28M	Buy	363,448 +12,176	+3%	+$891K	0.41%	58
2024 Q1	$24.1M	Sell	351,272 -11,626	-3%	-$748K	0.36%	73
2023 Q4	$21M	Sell	362,898 -5,971	-2%	-$319K	0.33%	81
2023 Q3	$19.5M	Buy	368,869 +791	+0.2%	+$41.5K	0.34%	78
2023 Q2	$19.9M	Sell	368,078 -2,409	-0.7%	-$126K	0.34%	80
2023 Q1	$18.5M	Buy	370,487 +3,607	+1%	+$170K	0.34%	84
2022 Q4	$17M	Buy	366,880 +9,211	+3%	+$399K	0.32%	90
2022 Q3	$13.9M	Sell	357,669 -67,837	-16%	-$2.72M	0.32%	85
2022 Q2	$15.9M	Sell	425,506 -5,704	-1%	-$232K	0.36%	79
2022 Q1	$19.1M	Buy	431,210 +3,843	+0.9%	+$167K	0.37%	73
2021 Q4	$18.2M	Sell	427,367 -32,582	-7%	-$1.37M	0.35%	78
2021 Q3	$20M	Sell	459,949 -55,416	-11%	-$2.45M	0.4%	65
2021 Q2	$22M	Buy	515,365 +8,733	+2%	+$367K	0.44%	58
2021 Q1	$19.6M	Sell	506,632 -34,487	-6%	-$1.31M	0.43%	65
2020 Q4	$19.5M	Sell	541,119 -18,153	-3%	-$654K	0.45%	61
2020 Q3	$21.4M	Buy	559,272 +14,344	+3%	+$553K	0.53%	52
2020 Q2	$19.1M	Buy	544,928 +101,258	+23%	+$3.65M	0.5%	52
2020 Q1	$14.5M	Buy	443,670 +21,661	+5%	+$846K	0.5%	55
2019 Q4	$19.1M	Buy	422,009 +11,076	+3%	+$463K	0.52%	59
2019 Q3	$16.7M	Buy	410,933 +3,107	+0.8%	+$132K	0.5%	62
2019 Q2	$17.5M	Buy	407,826 +90,900	+29%	+$3.5M	0.54%	61
2019 Q1	$12.2M	Buy	316,926 +32,761	+12%	+$1.25M	0.37%	92
2018 Q4	$10M	Buy	+284,165	New	+$10.3M	0.37%	87